These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2785727)

  • 1. Mink infected with Aleutian disease virus have an elevated level of CD8-positive T-lymphocytes.
    Aasted B
    Vet Immunol Immunopathol; 1989 Mar; 20(4):375-85. PubMed ID: 2785727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyses of leucocytes in blood and lymphoid tissues from mink infected with Aleutian mink disease parvovirus (AMDV).
    Chen W; Aasted B
    Vet Immunol Immunopathol; 1998 Jun; 63(4):317-34. PubMed ID: 9656422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine profiles in adult mink infected with Aleutian mink disease parvovirus.
    Jensen PV; Castelruiz Y; Aasted B
    J Virol; 2003 Jul; 77(13):7444-51. PubMed ID: 12805443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aleutian disease virus in B and T lymphocytes from blood and spleen and in bone marrow cells from naturally infected mink.
    Roth S; Kaaden OR; van Dawen S; Moennig V
    Intervirology; 1984; 22(4):211-7. PubMed ID: 6096293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus-specific B-lymphocytes are probably the primary targets for Aleutian disease virus.
    Aasted B; Leslie RG
    Vet Immunol Immunopathol; 1991 Apr; 28(2):127-41. PubMed ID: 1651029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial nephritis in Aleutian mink disease. Possible role of cell-mediated immunity against virus-infected tubular epithelial cells.
    Mori S; Nose M; Miyazawa M; Kyogoku M; Wolfinbarger JB; Bloom ME
    Am J Pathol; 1994 Jun; 144(6):1326-33. PubMed ID: 8203470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA vaccination with the Aleutian mink disease virus NS1 gene confers partial protection against disease.
    Castelruiz Y; Blixenkrone-Møller M; Aasted B
    Vaccine; 2005 Jan; 23(10):1225-31. PubMed ID: 15652664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mink with Aleutian disease have high-affinity antiviral antibodies.
    Aasted B; Bloom ME
    Scand J Immunol; 1984 May; 19(5):411-8. PubMed ID: 6328642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of Aleutian disease virus-specific lymphocyte response in mink with progressive Aleutian disease: comparison of sapphire and pastel mink infected with different virus strains.
    Race RE; Bloom ME; Coe JE
    J Immunol; 1983 Sep; 131(3):1558-64. PubMed ID: 6193194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of Aleutian mink disease parvovirus infection: effects of suppression of antibody response on viral mRNA levels and on development of acute disease.
    Alexandersen S; Storgaard T; Kamstrup N; Aasted B; Porter DD
    J Virol; 1994 Feb; 68(2):738-49. PubMed ID: 8289377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the quantity of antiviral antibodies from mink infected with different Aleutian disease virus strains.
    Aasted B; Tierney GS; Bloom ME
    Scand J Immunol; 1984 May; 19(5):395-402. PubMed ID: 6328641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of inapparent Aleutian disease virus infection in mink.
    An SH; DePauli FJ; Wright P; Ingram DG
    Res Vet Sci; 1978 Mar; 24(2):200-4. PubMed ID: 206934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and Immunogenicity Analysis of Whole-Gene Mutation DNA Vaccine of Aleutian Mink Virus Isolated Virulent Strain.
    Liu D; Li J; Shi K; Zeng F; Zong Y; Leng X; Lu H; Du R
    Viral Immunol; 2018; 31(1):69-77. PubMed ID: 28829241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restricted heterogeneity of the early antibody response to Aleutian disease virus in mink kits.
    Alexandersen S; Aasted B
    Acta Pathol Microbiol Immunol Scand C; 1986 Aug; 94(4):137-43. PubMed ID: 3024449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced severity of lesions in mink infected transplacentally with Aleutian disease virus.
    Porter DD; Larsen AE; Porter HG
    J Immunol; 1977 Sep; 119(3):872-6. PubMed ID: 70474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro synthesis of immunoglobulin and anti-viral antibody in Aleutian disease viral infection of mink.
    Perryman LE; McGuire TC; Banks KL
    J Immunol; 1976 Nov; 117(5 Pt.2):1981-4. PubMed ID: 993592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mink with Aleutian disease have autoantibodies to some autoantigens.
    Mouritsen S; Aasted B; Høier-Madsen M
    Vet Immunol Immunopathol; 1989 Nov; 23(1-2):179-86. PubMed ID: 2617848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of aleutian disease of mink: nature of the antiglobulin reaction and elution of antibody from erythrocytes and glomeruli of infected mink.
    Cho HJ; Ingram DG
    Infect Immun; 1973 Aug; 8(2):264-71. PubMed ID: 4199157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte abnormalities in Aleutian disease virus infection of mink: decreased T lymphocyte responses and increased B lymphocyte levels in persistent viral infection.
    Perryman LE; Banks KL; McGuire TC
    J Immunol; 1975 Jul; 115(1):22-7. PubMed ID: 1097504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aleutian mink disease parvovirus infection of K562 cells is antibody-dependent and is mediated via an Fc(gamma)RII receptor.
    Dworak LJ; Wolfinbarger JB; Bloom ME
    Arch Virol; 1997; 142(2):363-73. PubMed ID: 9125049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.